Monday, 22 June 2026
marketsViridian Therapeutics' shares plummeted 34% after its eye disease drug showed less efficacy than rivals despite a successful trial. This highlights risks in biopharma investments.
marketsElmet Group's US IPO filing reveals a revenue surge, highlighting its strategic expansion in the defense sector. This move offers opportunities for Indian investors.
marketsSysco's $29 billion acquisition of Restaurant Depot aims to expand its reach among independent restaurants, but investor concerns over debt and integration led to a 12% stock drop.



















